GlucoTrack Inc
(NASDAQ: GCTK)
GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company offers the GlucoTrack model DF-F glucose monitoring device, which utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements in less than one minute via a small sensor that is clipped onto one's earlobe and connected to a small, handheld control and display unit, all without drawing blood or interstitial fluid. It was designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain. The company was founded by Avner Gal and David Malka in September 2001 and is headquartered in Rutherford, NJ.
6.190
+0.210
(+3.51%)
Range
6.019 - 6.190
(2.84%)
Open
6.019
Previous Close
5.980
Bid Price
0.432
Bid Volume
10
Ask Price
0.440
Ask Volume
11
Volume
1,722
Value
-
Remark
View All Events
Loading Chart...
Please login to view stock data and analysis